Hexagon Nutrition IPO was launched as a Mainboard public issue through the book-building process, allowing investors to participate in the equity offering of Hexagon Nutrition Limited. The IPO was structured entirely as an Offer for Sale, enabling the existing shareholders to reduce a part of their ownership in the company. Since no fresh equity shares were issued, the company did not receive any capital from the public issue.
Hexagon Nutrition Limited operates in the nutrition and healthcare sector by manufacturing and supplying a wide range of nutrition products for domestic and international markets. Its product portfolio includes micronutrient premixes, clinical nutrition products, therapeutic foods, and other specialized nutritional solutions developed for various consumer and industrial applications. The company serves customers across multiple industries through its manufacturing facilities and distribution network.
This page provides comprehensive information about the Hexagon Nutrition IPO, including the issue details, subscription schedule, price band, lot size, reservation, company profile, financial performance, objectives of the offer, strengths, risk factors, and other important information that can help investors understand the public issue before making an investment decision.
Hexagon Nutrition IPO Details
Hexagon Nutrition Limited offered its equity shares through the Mainboard book-building route. The public issue consisted entirely of an Offer for Sale by the existing shareholders without any fresh issue component. Consequently, the proceeds from the IPO were received by the selling shareholders, while the company did not raise any additional funds through the public offering.
| IPO Details | Information |
|---|---|
| IPO Name | Hexagon Nutrition IPO |
| IPO Type | Book Built Issue |
| Issue Category | Mainboard IPO |
| Face Value | ₹1 per Equity Share |
| Price Band | ₹42 to ₹45 per Equity Share |
| Issue Price | ₹45 per Equity Share |
| Issue Size | ₹138.87 Crore (Approx.) |
| Fresh Issue | Nil |
| Offer for Sale | 3,08,59,704 Equity Shares |
| IPO Opens | 5 June 2026 |
| IPO Closes | 9 June 2026 |
| Basis of Allotment | 10 June 2026 |
| Listing Exchange | BSE & NSE |
| Listing Date | 12 June 2026 |
| Lot Size | 333 Shares |
| Minimum Investment | ₹14,985 |
| Issue Status | Listed |
Hexagon Nutrition IPO was offered through the Mainboard segment under the book-building mechanism and consisted solely of an Offer for Sale by the existing shareholders. Investors submitted applications within the prescribed subscription period through the ASBA or UPI process. As there was no fresh issue of equity shares, the public issue did not result in any fund infusion into the company, while the selling shareholders received the proceeds from the sale of their shares after applicable deductions.
Hexagon Nutrition IPO Dates & Timeline
Hexagon Nutrition IPO followed the standard schedule applicable to Mainboard book-built public issues in India. The public issue remained open for subscription for three trading days, after which the registrar finalized the basis of allotment, initiated the refund process for unsuccessful applicants, credited equity shares to successful investors’ demat accounts, and completed the listing process on the stock exchanges. The important IPO dates are provided below.
| Event | Date |
|---|---|
| Anchor Investor Bidding | 4 June 2026 |
| IPO Opening Date | 5 June 2026 |
| IPO Closing Date | 9 June 2026 |
| Basis of Allotment | 10 June 2026 |
| Initiation of Refunds | 11 June 2026 |
| Credit of Shares to Demat | 11 June 2026 |
| Listing Date | 12 June 2026 |
Investors were able to apply for the IPO through the ASBA facility or the UPI-based application process during the subscription period. After the allotment was finalized, blocked funds were released for unsuccessful applicants, while successful applicants received the allotted shares in their demat accounts before the company’s listing on BSE and NSE.
Hexagon Nutrition IPO Reservation
Hexagon Nutrition IPO followed the allocation structure prescribed by SEBI for Mainboard book-built public issues. The issue was allocated among Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), and Retail Individual Investors (RIIs) in accordance with the applicable regulatory framework.
| Investor Category | Reservation |
|---|---|
| Qualified Institutional Buyers (QIB) | Not More than 50% |
| Non-Institutional Investors (NII) | Not Less than 15% |
| Retail Individual Investors (RII) | Not Less than 35% |
Retail investors participated under the retail category, while applications exceeding the prescribed retail investment limit were treated under the non-institutional investor category. Qualified Institutional Buyers included eligible institutional investors participating under the relevant SEBI regulations.
Hexagon Nutrition IPO Lot Size
The minimum application for the Hexagon Nutrition IPO was one lot comprising 333 equity shares. Investors could apply for additional lots in multiples of the prescribed lot size, subject to the investment limits applicable to their respective categories. The investment requirement based on the issue price of ₹45 per share is shown below.
| Application Category | Lots | Shares | Investment |
|---|---|---|---|
| Retail (Minimum) | 1 | 333 | ₹14,985 |
| Retail (Maximum) | 13 | 4,329 | ₹194,805 |
| S-HNI (Minimum) | 14 | 4,662 | ₹209,790 |
| B-HNI (Minimum) | 67 | 22,311 | ₹10,03,995 |
Retail investors were permitted to submit applications up to the maximum investment limit specified for the retail category. Applications exceeding the applicable limit were considered under the non-institutional investor category. Investors were required to ensure that the application amount corresponded with the applicable lot size while submitting their IPO applications.
About Hexagon Nutrition Limited
Hexagon Nutrition Limited is a nutrition-focused healthcare company engaged in the development, manufacturing, marketing, and distribution of scientifically formulated nutritional products. The company offers a diversified portfolio that caters to preventive healthcare, clinical nutrition, food fortification, and wellness segments. Its products are supplied across India as well as numerous international markets.
The company’s product portfolio includes micronutrient premixes, therapeutic foods, clinical nutrition products, protein supplements, fortified food ingredients, and nutritional formulations designed for different age groups and health requirements. These products are supplied to food manufacturers, pharmaceutical companies, government nutrition programmes, hospitals, and institutional customers.
Hexagon Nutrition operates multiple manufacturing facilities equipped with modern production technology and quality management systems. The company emphasizes research and product innovation to develop nutrition solutions that comply with domestic and international quality standards while addressing changing consumer and industry requirements.
The company has established a presence in several countries through its export business and serves customers across Asia, Africa, the Middle East, Europe, and other international markets. Its diversified customer base reduces dependence on a single geography while supporting long-term business growth.
Going forward, Hexagon Nutrition intends to strengthen its market position by expanding its product portfolio, increasing manufacturing capabilities, investing in research and development, and enhancing its domestic as well as international distribution network.
Hexagon Nutrition Financial Performance
Hexagon Nutrition Limited has reported consistent business growth during the last three financial years. The company’s financial performance reflects growth in revenue, improving profitability, and continued expansion of its nutrition business across domestic and export markets.
| Financial Year | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
| Total Income | ₹631.84 Cr | ₹743.62 Cr | ₹848.95 Cr |
| EBITDA | ₹74.81 Cr | ₹92.67 Cr | ₹114.38 Cr |
| EBITDA Margin | 11.84% | 12.46% | 13.47% |
| Profit After Tax (PAT) | ₹35.28 Cr | ₹48.64 Cr | ₹64.72 Cr |
| PAT Margin | 5.58% | 6.54% | 7.62% |
| Net Worth | ₹234.17 Cr | ₹281.94 Cr | ₹345.63 Cr |
The financial performance indicates steady improvement in operating income and profitability during the reported period. Growth in sales, expansion across domestic and export markets, and operational efficiencies contributed to the company’s overall financial performance. Investors should also evaluate the complete financial statements, notes to accounts, and other disclosures contained in the Red Herring Prospectus before making an investment decision.
Objectives of the Hexagon Nutrition IPO
Hexagon Nutrition IPO consisted entirely of an Offer for Sale by the existing shareholders. As there was no fresh issue of equity shares, the company did not receive any proceeds from the public issue. The IPO primarily provided a partial exit opportunity to the selling shareholders while facilitating the listing of the company’s equity shares on the stock exchanges.
| Objective | Purpose |
|---|---|
| Offer for Sale | Existing shareholders offered part of their shareholding through the IPO. |
| Stock Exchange Listing | To list the company’s equity shares on BSE and NSE. |
| Liquidity for Shareholders | To provide liquidity and a partial exit opportunity to the selling shareholders. |
| Broader Shareholder Base | To increase public participation and expand the company’s shareholder base. |
Hexagon Nutrition IPO Strengths
Hexagon Nutrition Limited has built a strong presence in the nutrition and wellness industry through its diversified product portfolio, research-driven approach, and extensive domestic and international operations. The company focuses on developing nutritional solutions for healthcare, food fortification, and wellness applications while maintaining high manufacturing and quality standards. Some of the key strengths of the company are discussed below.
- Diversified Nutrition Product Portfolio – The company offers a broad range of nutritional products, including micronutrient premixes, clinical nutrition products, therapeutic foods, protein supplements, and fortified food ingredients. This diversified portfolio enables it to serve multiple customer segments across the healthcare and food industries.
- Strong Manufacturing Capabilities – Hexagon Nutrition operates modern manufacturing facilities equipped with advanced production technology and quality management systems. Its manufacturing infrastructure supports efficient production while maintaining product quality and regulatory compliance.
- Research and Product Development – The company places significant emphasis on research and innovation to develop science-based nutritional products. Continuous investment in product development enables it to introduce new formulations that address changing consumer preferences and industry requirements.
- Established Domestic and International Presence – Hexagon Nutrition supplies its products across India and exports to numerous international markets. Its diversified geographical presence helps reduce dependence on a single market while creating additional growth opportunities.
- Long-Term Customer Relationships – The company serves pharmaceutical companies, food manufacturers, hospitals, government nutrition programmes, and institutional customers. Long-standing relationships with a diversified customer base contribute to recurring business opportunities.
- Experienced Management Team – The company is managed by professionals with extensive experience in nutrition, healthcare, manufacturing, research, and business operations. Their expertise supports strategic decision-making and long-term business growth.
Risk Factors
Investment in the Hexagon Nutrition IPO involves certain risks that investors should evaluate carefully before making an investment decision. A detailed description of these risks is available in the Red Herring Prospectus.
- Dependence on Raw Material Availability – The company requires a continuous supply of vitamins, minerals, proteins, and other nutritional ingredients. Any disruption in procurement or significant increase in raw material prices may affect production costs and profitability.
- Regulatory Compliance Risk – The nutrition and healthcare industry is subject to various quality standards, food safety regulations, and statutory approvals. Changes in regulatory requirements may impact manufacturing operations or product approvals.
- Customer Concentration Risk – A portion of the company’s revenue is generated from key customers operating in the food, pharmaceutical, and healthcare sectors. Any reduction in orders or loss of major customers could affect financial performance.
- Foreign Exchange Risk – Since the company generates revenue from exports and imports certain raw materials, fluctuations in foreign currency exchange rates may influence operating margins and profitability.
- Competitive Industry Environment – The nutrition products industry is highly competitive, with participation from domestic as well as international manufacturers. Increased competition may affect pricing, market share, and future growth.
- Operational Risks – Manufacturing operations may be affected by equipment failures, supply chain disruptions, labour-related issues, or unexpected interruptions that could impact production schedules and customer deliveries.
Hexagon Nutrition IPO FAQs
What is Hexagon Nutrition IPO?
Hexagon Nutrition IPO was a Mainboard book-built public issue through which Hexagon Nutrition Limited offered its equity shares to public investors. The IPO consisted entirely of an Offer for Sale by the existing shareholders.
What was the price band of the Hexagon Nutrition IPO?
The price band for the Hexagon Nutrition IPO was fixed at ₹42 to ₹45 per equity share, while the final issue price was ₹45 per share.
What was the minimum investment required for retail investors?
Retail investors were required to apply for a minimum of one lot comprising 333 equity shares. At the issue price of ₹45 per share, the minimum investment amount was ₹14,985.
How were the IPO proceeds utilized?
Since the IPO consisted entirely of an Offer for Sale, Hexagon Nutrition Limited did not receive any proceeds from the public issue. The proceeds from the sale of shares were received by the selling shareholders after deducting the applicable issue expenses.
What does Hexagon Nutrition Limited do?
Hexagon Nutrition Limited develops, manufactures, and markets a wide range of nutritional products, including micronutrient premixes, clinical nutrition products, therapeutic foods, fortified food ingredients, and wellness solutions for domestic and international markets.
Where can investors check the IPO allotment status?
After the allotment process was completed, investors were able to check their allotment status on the official website of the IPO registrar using their PAN, application number, or DP/Client ID. The allotment details were also available on the websites of BSE and NSE.
